Officials cited data showing the new Alzheimer’s drug has serious safety risks and may not help patients.
Author: PAM BELLUCK
Advertisements
{
"slotId": "6845006044",
"unitType": "responsive",
"resize": "auto"
}Medicare Officially Limits Coverage of Aduhelm to Patients in Clinical Trials